These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 24689300)

  • 1. The co-identity of lipiarmycin A3 and tiacumicin B.
    Bedeschi A; Fonte P; Fronza G; Fuganti C; Serra S
    Nat Prod Commun; 2014 Feb; 9(2):237-40. PubMed ID: 24689300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Co-identity of Lipiarmycin A3 and Tiacumicin B.
    Bedeschi A; Fonte P; Fronza G; Fuganti C; Serra S
    Nat Prod Commun; 2016 May; 11(5):569-72. PubMed ID: 27319118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Final Demonstration of the Co-Identity of Lipiarmycin A3 and Tiacumicin B (Fidaxomicin) through Single Crystal X-ray Analysis.
    Serra S; Malpezzi L; Bedeschi A; Fuganti C; Fonte P
    Antibiotics (Basel); 2017 Feb; 6(1):. PubMed ID: 28208717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Total synthesis of the tiacumicin B (lipiarmycin A3/fidaxomicin) aglycone.
    Glaus F; Altmann KH
    Angew Chem Int Ed Engl; 2015 Feb; 54(6):1937-40. PubMed ID: 25510439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure and biological activity of lipiarmycin B.
    Cavalleri B; Arnone A; Di Modugno E; Nasini G; Goldstein BP
    J Antibiot (Tokyo); 1988 Mar; 41(3):308-15. PubMed ID: 3366689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Total synthesis of the protected aglycon of fidaxomicin (tiacumicin B, lipiarmycin A3).
    Miyatake-Ondozabal H; Kaufmann E; Gademann K
    Angew Chem Int Ed Engl; 2015 Feb; 54(6):1933-6. PubMed ID: 25431322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of tiacumicin B biosynthetic gene cluster affording diversified tiacumicin analogues and revealing a tailoring dihalogenase.
    Xiao Y; Li S; Niu S; Ma L; Zhang G; Zhang H; Zhang G; Ju J; Zhang C
    J Am Chem Soc; 2011 Feb; 133(4):1092-105. PubMed ID: 21186805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of a sugar-O-methyltransferase TiaS5 affords new Tiacumicin analogues with improved antibacterial properties and reveals substrate promiscuity.
    Niu S; Hu T; Li S; Xiao Y; Ma L; Zhang G; Zhang H; Yang X; Ju J; Zhang C
    Chembiochem; 2011 Jul; 12(11):1740-8. PubMed ID: 21633995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Genetic manipulation system for tiacumicin producer Dactylosporangium aurantiacum NRRL 18085].
    Xiao Y; Li S; Ma L; Zhang G; Ju J; Zhang C
    Wei Sheng Wu Xue Bao; 2010 Aug; 50(8):1014-22. PubMed ID: 20931868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. From natural product to marketed drug: the tiacumicin odyssey.
    Erb W; Zhu J
    Nat Prod Rep; 2013 Jan; 30(1):161-74. PubMed ID: 23111588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tiacumicin Congeners with Improved Antibacterial Activity from a Halogenase-Inactivated Mutant.
    Zhang H; Tian X; Pu X; Zhang Q; Zhang W; Zhang C
    J Nat Prod; 2018 May; 81(5):1219-1224. PubMed ID: 29676573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enantioselective synthesis of putative lipiarmycin aglycon related to fidaxomicin/tiacumicin B.
    Erb W; Grassot JM; Linder D; Neuville L; Zhu J
    Angew Chem Int Ed Engl; 2015 Feb; 54(6):1929-32. PubMed ID: 25422174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Molecular imprinted polymers for macrolides, aminoglycosides and some other biosynthetic antibiotics].
    Yakhkind MI; Tarantseva KR; Marynova MA; Storozhenko PA; Rasulov MM
    Antibiot Khimioter; 2014; 59(7-8):37-40. PubMed ID: 25975106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Total Synthesis of Tiacumicin A. Total Synthesis, Relay Synthesis, and Degradation Studies of Fidaxomicin (Tiacumicin B, Lipiarmycin A3).
    Hattori H; Kaufmann E; Miyatake-Ondozabal H; Berg R; Gademann K
    J Org Chem; 2018 Jul; 83(13):7180-7205. PubMed ID: 29590752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Production of brominated tiacumicin derivatives.
    Hochlowski JE; Jackson M; Rasmussen RR; Buko AM; Clement JJ; Whittern DN; McAlpine JB
    J Antibiot (Tokyo); 1997 Mar; 50(3):201-5. PubMed ID: 9127190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Letter: Isolation and structure of leuconolide-A3 5, 18-hemiacetal and 9-dehydro-18-dihydroleuconolide-A3.
    Omura S; Nakagawa A; Suzuki K; Hata T; Jakubowski A
    J Antibiot (Tokyo); 1974 Feb; 27(2):147-9. PubMed ID: 4826089
    [No Abstract]   [Full Text] [Related]  

  • 17. Kibdelomycin A, a congener of kibdelomycin, derivatives and their antibacterial activities.
    Singh SB; Goetz MA; Smith SK; Zink DL; Polishook J; Onishi R; Salowe S; Wiltsie J; Allocco J; Sigmund J; Dorso K; de la Cruz M; Martín J; Vicente F; Genilloud O; Donald RG; Phillips JW
    Bioorg Med Chem Lett; 2012 Dec; 22(23):7127-30. PubMed ID: 23084277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on a new aminoglycoside antibiotic, dactimicin. II. Isolation, structure and chemical degradation.
    Ohba K; Tsuruoka T; Mizutani K; Kato N; Omoto S; Ezaki N; Inouye S; Niida T; Watanabe K
    J Antibiot (Tokyo); 1981 Sep; 34(9):1090-100. PubMed ID: 7328051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucopiericidin C: a cytotoxic piericidin glucoside antibiotic produced by a marine Streptomyces isolate.
    Shaaban KA; Helmke E; Kelter G; Fiebig HH; Laatsch H
    J Antibiot (Tokyo); 2011 Feb; 64(2):205-9. PubMed ID: 21081953
    [No Abstract]   [Full Text] [Related]  

  • 20. Phenelfamycins G and H, new elfamycin-type antibiotics produced by Streptomyces albospinus Acta 3619.
    Brötz E; Kulik A; Vikineswary S; Lim CT; Tan GY; Zinecker H; Imhoff JF; Paululat T; Fiedler HP
    J Antibiot (Tokyo); 2011 Mar; 64(3):257-66. PubMed ID: 21285962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.